These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15380632)

  • 1. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Control Release; 2004 Sep; 99(2):217-29. PubMed ID: 15380632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
    Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
    Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro drug release mechanism and drug loading studies of cubic phase gels.
    Lara MG; Bentley MV; Collett JH
    Int J Pharm; 2005 Apr; 293(1-2):241-50. PubMed ID: 15778062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
    Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
    Micron; 2007; 38(5):478-85. PubMed ID: 17011783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Pharm Sci; 2005 Mar; 94(3):481-92. PubMed ID: 15619248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
    Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
    Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
    Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.
    Borgheti-Cardoso LN; Depieri LV; Kooijmans SA; Diniz H; Calzzani RA; Vicentini FT; van der Meel R; Fantini MC; Iyomasa MM; Schiffelers RM; Bentley MV
    Eur J Pharm Sci; 2015 Jul; 74():103-17. PubMed ID: 25917525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New lipid family that forms inverted cubic phases in equilibrium with excess water: molecular structure-aqueous phase structure relationship for lipids with 5,9,13,17-tetramethyloctadecyl and 5,9,13,17-tetramethyloctadecanoyl chains.
    Yamashita J; Shiono M; Hato M
    J Phys Chem B; 2008 Oct; 112(39):12286-96. PubMed ID: 18774852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.